SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Keel Infrastructure Corp. engages in building artificial intelligence focused data centers and energy assets. It focuses on infrastructure and energy required to support high-performance computing and artificial intelligence workloads. The company was founded on April 1, 2026 and is headquartered in New York, NY.

Keel Infrastructure Corp.

Keel Infrastructure Corp

Keel Infrastructure Corp is trending as investors bet on the companys pivot from crypto mining to AI-focused data center infrastructure. The community is actively discussing rumors of imminent lease contracts and positive technical momentum, with many highlighting the potential for a rerating as the company integrates into major market indices.

QuantumScape Corp. engages in developing next-generation solid-state lithium-metal batteries. The company’s next-generation batteries are designed to enable greater energy density, faster charging, and enhanced safety to support the transition away from legacy energy sources toward a lower-carbon future. The company was founded by Jagdeep Singh, Tim Holme, and Fritz B. Prinz in May 2010 and is headquartered in San Jose, CA.

QuantumScape Corp - Ordinary Shares - Class A

QuantumScape Corp

QuantumScape is seeing significant market momentum following a multi-year joint research agreement with Honda, which validates the scalability and performance of its solid-state battery platform. Community sentiment is largely bullish, with investors actively discussing the company's expanding OEM ecosystem, potential applications in AI data centers, and the strategic importance of securing a second major automotive partner beyond Volkswagen.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is trending as investors digest positive Phase 3 VELA-program data, which demonstrates durable efficacy and a clean safety profile for sonelokimab in treating hidradenitis suppurativa. The community is actively discussing the stock's best-in-class potential and the likelihood of a strategic buyout as the company moves toward BLA submission.

Definium Therapeutics, Inc. operates as clinical stage biopharmaceutical company, which engages in developing novel product candidates to treat brain health disorders. The company was founded by Stephen L. Hurst, Scott M. Freeman, Leonard Latchman and Jamon Alexander Rahn on July 26, 2010 and is headquartered in New York, NY.

Definium Therapeutics Inc.

Definium Therapeutics is trending due to positive topline Phase 3 data for its depression treatment, triggering significant investor interest and ongoing debate regarding its potential for commercial success against established psychedelic peers. Community discussions center on the company's clinical trial catalysts, cash runway, and the binary nature of upcoming data readouts in the competitive mental health space.

Aurinia Pharmaceuticals, Inc. is a clinical stage bio-pharmaceutical company, which engages in the research, development, and commercialization of therapeutic drugs. The company was founded by Robert Foster, Richard Glickman, and Michael Martin on June 16, 1993 and is headquartered in Edmonton, Canada.

Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals is attracting intense community interest as high volume and unusual pre-market activity fuel speculation regarding a potential buyout or upcoming catalyst for the AUR200 pipeline. Investors are closely monitoring CEO Kevin Tang's significant share accumulation while debating the impact of ongoing patent litigation and the strategic silence from the new management team.

Chevron Corp. engages in the provision of oil and gas energy solutions. It provides crude oil and natural gas, manufactures transportation fuels, lubricants, petrochemicals, and additives, and develops technologies that enhance business and the industry. It operates through the Upstream and Downstream segments. The Upstream segment consists of the exploration, development, and production of crude oil and natural gas, the liquefaction, transportation, and regasification associated with liquefied natural gas, the transporting of crude oil by major international oil export pipelines, the processing, transporting, storage, and marketing of natural gas, and a gas-to-liquids plant. The Downstream segment consists of the refining of crude oil into petroleum products, the marketing of crude oil and refined products, the transporting of crude oil and refined products by pipeline, marine vessel, motor equipment, and rail car, and the manufacturing and marketing of commodity petrochemicals and plastics for industrial uses and fuel & lubricant additives. The company was founded on September 10, 1879 and is headquartered in Houston, TX.

Chevron Corp.

Chevron (CVX) is trending as investors weigh strong operational performance and dividend reliability against the geopolitical risks of the Strait of Hormuz conflict. The community is actively debating the stock's resilience, with many noting that persistent supply disruptions and energy security themes continue to act as key catalysts for the sector.

Roundhill ETF Trust - Roundhill Memory ETF

The Roundhill Memory ETF (DRAM) is trending as investors capitalize on the structural AI-driven demand for HBM and storage, despite broader market volatility and uncertainty surrounding major upcoming IPOs. Community sentiment remains overwhelmingly bullish, with many participants framing the current price action as a strategic entry point for a long-term re-rating of the memory sector beyond its traditional cyclical history.

REGENXBIO, Inc. is a clinical-stage biotechnology company, which engages in the development, commercialization, and licensing of recombinant adeno-associated virus gene therapy. Its product candidates include the NAV Technology Platform, which consists of exclusive rights to novel adeno-associated viral vectors, and therapeutic programs such as RGX-314, RGX-202, RGX-121, RGX-111, RGX-181, and RGX-381. The company was founded by Kenneth T. Mills and James M. Wilson on July 16, 2008 and is headquartered in Rockville, MD.

Regenxbio Inc

Regenxbio is in the spotlight following the FDA's decision to issue a Complete Response Letter (CRL) for its Hunter syndrome gene therapy, NAVSUNLI, effectively rejecting the current application while demanding additional data. Investors are now shifting their focus toward the company's long-term pipeline potential, specifically the RGX-202 program for Duchenne muscular dystrophy and the ongoing wet AMD collaboration with AbbVie, as the community debates whether current valuations adequately reflect the company's remaining cash runway and development milestones.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

Sandisk is trending as investors aggressively bid up memory stocks, fueled by reports of structural storage shortages and AI-driven data center demand. The community is actively debating the sustainability of this parabolic run, with some traders highlighting the stock's record-setting RSI as a sign of an overheating market while others point to institutional re-rating as evidence of a sustained supercycle.

SPDR Series Trust - State Street SPDR S&P Biotech ETF

SPDR S&P Biotech ETF

The SPDR S&P Biotech ETF (XBI) is trending as investors monitor a rotation into the biotech sector, fueled by anticipation of key clinical trial readouts and potential M&A activity despite broader market volatility. Community discourse remains heavily focused on the high-risk, high-reward profiles of individual companies like SLS and IBRX, with many users tracking short interest, pipeline milestones, and regulatory catalysts.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Why Motorcar Parts of America Surged Nearly 35% Higher Today

Key PointsIt also posted net sales growth of almost 10...

Motorcar Parts of America Reports Q4 2026 Results: Full Earnings Call Transcript

Motorcar Parts of America Reports Fiscal 2026 Year-End Results

Motorcar Parts of America, Inc. (Nasdaq: MPAA) today reported financial results for its fiscal 2026 fourth quarter and year ended March 31 reflecting solid sales, gross profit and net income for both periods. Fourth Quarter Highlights: Net sales increased 9.9 percent to $212.3 million. Gross profit...

Motorcar Parts Of America, Campbell's And 3 Stocks To Watch Heading Into Monday

US stock futures mixed, Motorcar Parts of America, Campbell's Co and Mission Produce expected to report earnings.read more...

Motorcar Parts of America to Report Fiscal 2026 Fourth Quarter and Year-End Results; Host Conference Call

Motorcar Parts of America, Inc. (Nasdaq: MPAA) today announced the company will issue its fiscal 2026 fourth quarter and year-end results on Monday, June 8, 2026. Selwyn Joffe, chairman, president and chief executive officer, and David Lee, chief financial officer, will host an investor conference...

Motorcar Parts of America to Present at 26th Annual Oppenheimer Consumer Conference

Motorcar Parts of America, Inc. (Nasdaq:MPAA) today announced the company is scheduled for a fireside chat presentation on Tuesday, June 9, 2026 at 11:15 a.m. Eastern time at the 26th Annual Oppenheimer Consumer Growth & E-Commerce Conference being held in a virtual format. A live webcast of the...

140,629 Shares in Motorcar Parts of America, Inc. $MPAA Purchased by Segall Bryant & Hamill LLC

Segall Bryant & Hamill LLC purchased a new stake in Motorcar Parts of America, Inc. (NASDAQ:MPAA - Free Report) in the 3rd quarter, according to the company in its most recent 13F filing with the...

Motorcar Parts of America, Inc. (NASDAQ:MPAA) Short Interest Up 21.0% in February

Motorcar Parts of America, Inc. (NASDAQ:MPAA - Get Free Report) was the recipient of a large increase in short interest in February. As of February 13th, there was short interest totaling 851,183...

Motorcar Parts of America (NASDAQ:MPAA) Stock Rating Lowered by Wall Street Zen

Wall Street Zen lowered shares of Motorcar Parts of America from a "buy" rating to a "hold" rating in a research note on Saturday...

Motorcar Parts of America Q3 Earnings Call Highlights

Motorcar Parts of America (NASDAQ:MPAA) executives told investors their fiscal 2026 third-quarter performance fell short of expectations due largely to a sharp, temporary sales disruption at one of...

Motorcar Parts of America, Inc. engages in the manufacture, remanufacture, and distribution of automotive parts. It operates through the following segments: Hard Parts, Test Solutions and Diagnostic Equipment, and Heavy Duty. The Hard Parts segment is composed of light duty rotating electric products such as alternators and starters, wheel hub products, and brake-related products. The Test Solutions and Diagnostic Equipment segment represents bench top testers for alternators and starters, test solutions and diagnostic equipment for the pre- and post-production of electric vehicles, and software emulation of power systems applications for the electrification of all forms of transportation. The Heavy Duty segment deals with non-discretionary automotive aftermarket replacement hard parts for heavy-duty truck, industrial, marine, and agricultural applications. The company was founded by Mel Marks in 1968 and is headquartered in Torrance, CA.

Motorcar Parts of America Inc.

Top 5 Auto Stocks That Had Retail Traders Revved Up Last Week

Equity

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$15.36
Prev Close	$14.93
Open	$15.13
Dividend Yield	0.00%
50-Day Moving Average	$11.80
Beta	1.01
Avg. Volume	43,324.60
PE Ratio	27.31

52-Week High	$18.12
52-Week Low	$9.29
Market Capitalization	$290.69M
EPS (Annual)	$0.6204
Price to Book	1.09
Revenue Per Employee	$141,036.79

MPAAMotorcar Parts of America Inc.

Fundamentals

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest MPAA News